Kamal Bhatia practices Psychiatry. He studied medicine at University of Kansas School of Medicine. Kamal Bhatia is a published doctor as well. He has 3 publications published. The latest was: Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine. He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1255568010 | |
NPPES Provider LastName | BHATIA | |
NPPES Provider FirstName | KAMAL | |
NPPES Provider ZIPCode | 217421435 | |
NPPES Provider State | MD | |
Specialty Description | Neuropsychiatry | |
Total Claim Count | 31.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1255568010 |
Last Name Of The Provider | BHATIA |
First Name Of The Provider | KAMAL |
View All |
![]() |
Dr. Bartholomew T. Hogan, MD |
![]() |
Dr. Garry A. Seligman, MD
![]() |
![]() |
Dr. Olga P. Demina, MD
![]() |
![]() |
Dr. Terri A. Sears-Nickens, MD |
![]() |
Dr. Jennifer L. Mettlen, MD
![]() |